These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6398336)

  • 1. Enhanced response of plasma aldosterone to metoclopramide in essential hypertension.
    Stern N; Sowers JR; Tuck M; Eshkol A; Lunenfeld B; Rosenthal T
    J Hypertens; 1984 Apr; 2(2):209-14. PubMed ID: 6398336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic modulation of pressor and hormonal responses in essential hypertension.
    Sowers JR; Golub MS; Berger ME; Whitfield LA
    Hypertension; 1982; 4(3):424-30. PubMed ID: 6279498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of upright posture on the aldosterone responses to dopamine, metoclopramide, angiotensin II, and adrenocorticotropin.
    Malchoff CD; Hughes JM; Carey RM
    J Clin Endocrinol Metab; 1987 Jul; 65(1):203-7. PubMed ID: 3034955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered dopaminergic modulation of prolactin and aldosterone secretion in pseudohypoparathyroidism.
    Sowers JR; Brickman AS; Asp N; Tuck ML; Jasberg K; Magnone S
    J Clin Endocrinol Metab; 1981 May; 52(5):914-8. PubMed ID: 7014587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine reduces aldosterone and 18-hydroxycorticosterone response to angiotensin II in patients with essential low-renin hypertension and idiopathic hyperaldosteronism.
    Witzgall H; Lorenz R; von Werder K; Weber PC
    Clin Sci (Lond); 1985 Mar; 68(3):291-9. PubMed ID: 3882312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic modulation of aldosterone secretion: effect of sodium balance and postural changes.
    García-Robles R; Ruilope L; Mancheño E; Hurtado A; Alcázar JM; Varela C; de la Calle H; Rodicio JL; Sancho J
    Rev Esp Fisiol; 1984 Mar; 40(1):63-8. PubMed ID: 6087430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of metoclopramide, a dopamine antagonist, on secretion of aldosterone and renin release in patients with primary aldosteronism.
    Mizuno K; Yamazaki M; Ikeda K; Yaginuma K; Hashimoto S; Fukuchi S
    Jpn Heart J; 1983 Nov; 24(6):917-24. PubMed ID: 6323781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum aldosterone response to metoclopramide in normal subjects and acromegalic patients.
    Zacharieva S; Stoeva I; Matrozov P; Andonova K
    Exp Clin Endocrinol; 1990 Aug; 95(3):331-8. PubMed ID: 2245821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of fenoldopam on the aldosterone response to metoclopramide in man.
    Dupont AG; Vanderniepen P; Volckaert A; Smitz J; Vansteirteghem AC; Six RO
    Clin Endocrinol (Oxf); 1986 Feb; 24(2):203-8. PubMed ID: 2871951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoreactive endogenous ouabain in primary aldosteronism and essential hypertension: relationship with plasma renin, aldosterone and blood pressure levels.
    Rossi G; Manunta P; Hamlyn JM; Pavan E; De Toni R; Semplicini A; Pessina AC
    J Hypertens; 1995 Oct; 13(10):1181-91. PubMed ID: 8586810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pressor and hormonal responses to intravenous injection of metoclopramide in normotensive and hypertensive patients.
    Kawabe H; Suzuki H; Itaya Y; Saruta T
    Jpn J Med; 1990; 29(2):174-9. PubMed ID: 2232366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic modulation of aldosterone secretion in the normal menstrual cycle.
    Garcia-Robles R; Ruilope LM; Tovar J; de Pablos P; Parada J; Hurtado A; Miranda B; Fernandez Vazquez G; Rodicio JL; Sancho J
    J Clin Hypertens; 1987 Dec; 3(4):470-8. PubMed ID: 3134515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopaminergic control of aldosterone secretion in hypertensive patients chronically treated with an angiotensin converting enzyme inhibitor.
    Waeber B; Nussberger J; Schaller MD; Gomez HJ; Brunner HR
    Horm Metab Res; 1986 Jan; 18(1):60-3. PubMed ID: 3005150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced response to metoclopramide and anomalous rising response to upright posture of plasma aldosterone concentration in Japanese patients with aldosterone-producing adenoma.
    Mune T; Morita H; Yasuda K; Yamakita N; Miura K
    J Clin Endocrinol Metab; 1993 Oct; 77(4):1020-7. PubMed ID: 8408449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin secretion in essential hypertension.
    Stern N; Eshkol A; Lunenfeld B; Rosenthal T
    Clin Exp Hypertens A; 1983; 5(4):543-58. PubMed ID: 6342865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic control of aldosterone secretion is independent of the renin-angiotensin system in rats.
    Sowers JR; Tuck ML; Barrett J; Sambhi MP; Golub MS
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():101s-103s. PubMed ID: 7004716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of aldosterone secretion by metoclopramide is not affected by chronic converting enzyme inhibition.
    Dupont AG; Vanderniepen P; Smitz JJ; Six RO
    Eur J Clin Pharmacol; 1985; 29(2):207-10. PubMed ID: 3000795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metoclopramide and domperidone block the antihypertensive effect of bromocriptine in hypertensive patients.
    Luchsinger A; Grilli M; Velasco M
    Am J Ther; 1998 Mar; 5(2):81-8. PubMed ID: 10099042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic control of serum potassium.
    Bevilacqua M; Norbiato G; Raggi U; Micossi P; Baggio E; Prandelli M
    Metabolism; 1980 Apr; 29(4):306-10. PubMed ID: 6990171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Excess of mineralocorticoids in essential hypertension: clinical-diagnostic approach].
    Cortés P; Fardella C; Oestreicher E; Gac H; Mosso L; Soto J; Foradori A; Claverie X; Ahuad J; Montero J
    Rev Med Chil; 2000 Sep; 128(9):955-61. PubMed ID: 11349499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.